Targeted indications include respiratory infections in patents with cystic fibrosis, chronic obstructive pulmonary diseases, ventilator associated pneumonia and fungal pneumonia.
Targeted indications include respiratory infections in patents with cystic fibrosis, chronic obstructive pulmonary diseases, ventilator associated pneumonia and fungal pneumonia.